Skip to main content

Table 1 Histopathological and clinical features in published series of patients with OFMT

From: Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor

Study

Number of patients (total/FU)

Histological subtype (T, A, M)

Median follow-up (months)

Follow-up information

Outcome

Enzinger et al. [1]

59/41

N/A

N/A

11 LR

1 DM

3 DoC

Folpe et al. [6]

70/51

N/A

36

9 LR

8 DM

41 NED

6 ED

4 DoD

1 DoC

Miettinen et al. [3]

104/41

N/A

156

9 LR

32 UNK

16 DoC

5 NED

Graham et al. [15]

46/27

T = 26

A = 5 

M = 15

55

2 LR (M)

3 DM (M)

3 DoD

Atanaskova Mesinkova et al. [4]

26/16

T = 8

A = 13 

M = 5

45

3 LR (M)

1 DM (M)

N/A

Kossivi Dantey et al. [5]

6/6

A = 1 

M = 5

27

No events

1 DoC

  1. FU follow-up, T typical, A atypical, M malignant, N/A not available, LR Local relapse, DM distant metastasis, DoC dead of other cause, NED not evident disease, ED evident disease, DoD dead of disease, UNK unknown